India Lab Recalls 27 Eye Drops From U.S. Pharmacies
Another Indian lab recalling eye drops following recalls in October and instances of blindness caused by other imports from India in March.
Congress Can Fix the Dangerous Dependence on Imported Pharmaceuticals
In the wake of the COVID pandemic, consumers have become painfully aware of America’s heavy dependence on imports. The recent Amoxicillin shortage in hospitals has
CPA Applauds Congresswoman Tenney’s PILLS Act, Legislation to Boost U.S. Domestic Production of Generic Medicines
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded the introduction of the Producing Incentives for Long-term Production of Lifesaving Supply of Medicines
Candidate Trump Announces Plans to Reshore Essential Medicines to Avoid Drug Shortages
Trump’s call to reshore pharmaceutical production, especially critical medicine in short supply, will set the table for other presidential candidates. Reshoring America’s medicine supply chain is increasingly mainstream, and an easy sell to voters.
FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
House Committee Holds Hearing on Drug Shortages
The U.S. is increasingly reliant on imported drugs from uninspected labs. It’s not safe. What can be done about it?
Drug Shortages: Why They Happen, What Can Be Done About Them?
A Senate hearing on pharmaceutical shortages discusses America’s dependence on India and China, and what can be done to reshore.
CPA Urges Biden Administration to End Suspension of Tariffs on PPE Imports
America needs to be prepared for the next health crisis WASHINGTON — The Coalition for a Prosperous America (CPA) urged the U.S. Trade Representative (USTR)
Why Medicine Costs So Much Money, Despite Imports from Low-Cost Nations
The Senate Commerce Committee takes the little known, and even less understood, Pharmacy Benefit Manager industry to task for high drug costs.
